Msn - Profile
✉ Email this page to a colleague
Drugs and US Patents for Msn
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Msn | CHLORPROMAZINE HYDROCHLORIDE | chlorpromazine hydrochloride | TABLET;ORAL | 214827-003 | Jan 27, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Msn | OBETICHOLIC ACID | obeticholic acid | TABLET;ORAL | 215017-002 | May 30, 2023 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Msn | ROFLUMILAST | roflumilast | TABLET;ORAL | 208256-001 | Sep 7, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Msn | LISDEXAMFETAMINE DIMESYLATE | lisdexamfetamine dimesylate | TABLET, CHEWABLE;ORAL | 218306-001 | Feb 2, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Msn | LISDEXAMFETAMINE DIMESYLATE | lisdexamfetamine dimesylate | TABLET, CHEWABLE;ORAL | 218306-006 | Feb 2, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Msn | DOFETILIDE | dofetilide | CAPSULE;ORAL | 213220-002 | Jan 29, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Msn Labs Pvt Ltd | AZACITIDINE | azacitidine | POWDER;INTRAVENOUS, SUBCUTANEOUS | 212580-001 | May 16, 2024 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
